| |
|
|
|
Adial Pharmaceuticals Inc.  
|
|
1.44 -0.11 (-0.07%) |
11-22 11:10 |
|
Open: |
1.4675 |
Pre close: |
1.55 |
Target:
|
1.89 
|
|
High: |
1.47 |
Low: |
1.41 |
Resistance:
|
1.62
1.75
|
|
Volume: |
2,818 |
Market Cap: |
15M |
Support:
|
1.41
1.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.49
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.57 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
1.64 |
Stochastic Oscillator |
%K(14,3):
|
14.11 |
|
MA(250): |
2.76 |
%D(3): |
16.08 |
|
Average Volume(K) |
3-Month: |
4294
|
52-Week |
High:
|
9.44 |
|
10-Days: |
2424 |
Low: |
1.30 |
|
RSI |
RSI(14):
|
43.21 |
Change(%): |
-14.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.861 |
Return on Equity (ttm) |
-325.7 |
Shares Out. (M) |
10.24 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-107.1 |
Shares Float (M) |
6.47 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
35.30 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.68 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
49 |
|
Book Value (p.s.) |
0.980 |
EBITDA (p.s.) |
-0.909 |
P/E |
-0.76 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.45 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.96 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.93 |
P/CF |
-2.93 |
|
|
|
|
|
|
